Event Date/Time: Jun 06, 2005
End Date/Time: Jun 08, 2005
IBC’s Evaluating Preclinical Drug Safety will review in vitro, in vivo, and in silico approaches to predicting drug safety. Hear from experts from Eli Lilly, Abbott Laboratories, AstraZeneca, F.Hoffmann-La Roche, Ltd., Novartis Institutes for Biomedical Research, the FDA’s National Center for Toxicological Research and more. As a registered attendee for the Evaluating Preclinical Drug Safety conference, you will be able to attend the co-located Early Efficacy Assessment conferences at no charge! To register or view full details, visit www.IBCLifeSciences.com/3141 or call +1 508-616-5550 x1004.